• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主题演讲:临床放射治疗当前及未来实践的科学基础

Keynote address: the scientific basis of the present and future practice of clinical radiotherapy.

作者信息

Fletcher G H

出版信息

Int J Radiat Oncol Biol Phys. 1983 Jul;9(7):1073-82. doi: 10.1016/0360-3016(83)90399-1.

DOI:10.1016/0360-3016(83)90399-1
PMID:6345488
Abstract

At mid-century radiotherapy was more an art than a science, but is presently based on radiobiological parameters and cell kinetics. This close interaction between basic scientific principles and clinical practice has been made possible because one can correlate quantitatively doses of irradiation with observed responses. First, a short historical review will be made because it gives a perspective for the understanding both of progress made and prevailing misconceptions. The important radiobiological parameters and cell kinetics will then be discussed in some detail to demonstrate that they should be thoroughly understood in their relationship to radiotherapy. The overall treatment planning must be based on the clinical applications of the main radiobiological parameters. The combined treatment with surgery, either pre- or postoperatively, and multiple daily fractionations will be used as examples. The teaching of radiobiology should be considerably expanded, not only for its own scientific merit but also to show how it applies to clinical situations. This should be reflected in the expansion of the board examination.

摘要

在本世纪中叶,放射治疗与其说是一门科学,不如说是一门艺术,但目前它是基于放射生物学参数和细胞动力学的。基础科学原理与临床实践之间的这种紧密互动之所以成为可能,是因为人们可以将照射剂量与观察到的反应进行定量关联。首先,将进行简短的历史回顾,因为它为理解所取得的进展和普遍存在的误解提供了一个视角。然后将详细讨论重要的放射生物学参数和细胞动力学,以表明它们与放射治疗的关系应该得到透彻理解。总体治疗计划必须基于主要放射生物学参数的临床应用。以手术的术前或术后联合治疗以及每日多次分割治疗为例。放射生物学的教学应该大幅扩展,这不仅是因为其自身的科学价值,还因为要展示它如何应用于临床情况。这应该体现在委员会考试的扩展中。

相似文献

1
Keynote address: the scientific basis of the present and future practice of clinical radiotherapy.主题演讲:临床放射治疗当前及未来实践的科学基础
Int J Radiat Oncol Biol Phys. 1983 Jul;9(7):1073-82. doi: 10.1016/0360-3016(83)90399-1.
2
The eighteenth Douglas Lea lecture. 40 years of radiobiology: its impact on radiotherapy.第18届道格拉斯·利讲座。放射生物学40年:其对放射治疗的影响。
Phys Med Biol. 1984 Feb;29(2):97-113. doi: 10.1088/0031-9155/29/2/002.
3
[Radiobiological analysis of the use of low-intensity irradiation doses in radiation therapy].[放射治疗中低强度照射剂量使用的放射生物学分析]
Med Radiol (Mosk). 1980 Aug;25(8):68-74.
4
Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.关于:罗森塔尔·迪、格拉茨坦·埃。《我们有了一种治疗方法,但疾病是什么?》,《肿瘤学家》1996年;第1期。
Oncologist. 1997;2(1):59-61.
5
An historical survey of radiobiology and radiotherapy with fast neutrons.快中子放射生物学与放射治疗的历史综述。
Curr Top Radiat Res Q. 1976 Jan;11(1):1-86.
6
Radiation biology.放射生物学
Cancer. 1985 May 1;55(9 Suppl):2051-7. doi: 10.1002/1097-0142(19850501)55:9+<2051::aid-cncr2820551404>3.0.co;2-y.
7
Hypothesis. Elkind recovery and "sub-lethal damage": a misleading association?假设。埃尔金德恢复与“亚致死损伤”:一种误导性的关联?
Br J Radiol. 1977 Jul;50(595):459-67. doi: 10.1259/0007-1285-50-595-459.
8
Recent developments in fundamental radiobiology.基础放射生物学的最新进展。
Cancer. 1968 Oct;22(4):802-8. doi: 10.1002/1097-0142(196810)22:4<802::aid-cncr2820220417>3.0.co;2-a.
9
Discussion of radiobiological factors operating in low dose rate irradiation.低剂量率辐照中放射生物学因素的探讨。
Radiol Clin (Basel). 1978;47(2):132-8.
10
Radiobiological considerations for pions in radiotherapy.放射治疗中π介子的放射生物学考量
Oncology. 1971;25(6):536-57. doi: 10.1159/000224605.

引用本文的文献

1
Evaluation of Tumor Control and Normal Tissue Complication Probabilities in Patients Receiving Comprehensive Nodal Irradiation for Left-Sided Breast Cancer.评估接受左侧乳腺癌综合淋巴结照射的患者的肿瘤控制和正常组织并发症概率。
Curr Oncol. 2024 May 31;31(6):3189-3198. doi: 10.3390/curroncol31060241.
2
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC.使用 NSCLC 中放射敏感性和正常组织毒性的基因组标记来个性化放射治疗处方剂量。
J Thorac Oncol. 2021 Mar;16(3):428-438. doi: 10.1016/j.jtho.2020.11.008. Epub 2020 Dec 8.
3
High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis.
现代放疗技术下食管癌同步放化疗高剂量与低剂量辐射的比较:一项荟萃分析
Front Oncol. 2020 Aug 4;10:1222. doi: 10.3389/fonc.2020.01222. eCollection 2020.
4
Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.II-III期食管癌患者接受根治性放化疗时辐射剂量与局部区域控制之间的剂量反应关系
Cancer Res Treat. 2017 Jul;49(3):669-677. doi: 10.4143/crt.2016.354. Epub 2016 Oct 6.
5
[The locoregional recurrence of rectal carcinoma. A computed tomographic analysis and a target volume concept for adjuvant radiotherapy].[直肠癌的局部区域复发。计算机断层扫描分析及辅助放疗的靶区概念]
Strahlenther Onkol. 1997 Feb;173(2):68-75. doi: 10.1007/BF03038925.
6
Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum.可临床切除的直肠癌术前放射治疗
Ann Surg. 1985 Aug;202(2):215-22. doi: 10.1097/00000658-198508000-00012.